NCT05054062View on ClinicalTrials.gov

Sentinel Lymph Node Mapping Using Magtrace and MRI in Healthy Subjects for Potential Use in Melanoma Patients

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

August 20, 2021

Study Completion Date

August 20, 2021

Conditions
Melanoma
Interventions
DIAGNOSTIC_TEST

Sentinel node mapping using MRI

Sentinel lymph node mapping in melanoma patients using a magnetic tracer and MRI

Trial Locations (1)

6162BG

Zuyderland Medical Center, Sittard

All Listed Sponsors
lead

Zuyderland Medisch Centrum

OTHER

NCT05054062 - Sentinel Lymph Node Mapping Using Magtrace and MRI in Healthy Subjects for Potential Use in Melanoma Patients | Biotech Hunter | Biotech Hunter